HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christian Meisel Selected Research

Mannose-Binding Lectin (Mannan-Binding Lectin)

10/2015Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome.
6/2013Impaired thymic function and CD4+ T lymphopenia, but not mannose-binding lectin deficiency, are risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christian Meisel Research Topics

Disease

33Infections
01/2023 - 05/2003
30Stroke (Strokes)
11/2023 - 09/2003
13Pneumonia (Pneumonitis)
01/2021 - 10/2006
13Sepsis (Septicemia)
02/2020 - 12/2005
9COVID-19
02/2023 - 01/2020
8Ischemic Stroke
11/2023 - 05/2008
8Inflammation (Inflammations)
02/2023 - 08/2007
6Disease Progression
01/2022 - 10/2009
6Epilepsy (Aura)
01/2022 - 01/2020
5Autoimmune Diseases (Autoimmune Disease)
01/2022 - 09/2009
5Polyneuropathies (Polyneuropathy)
01/2022 - 06/2015
5Fever (Fevers)
01/2022 - 01/2004
5Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2021 - 08/2007
4Brain Ischemia (Cerebral Ischemia)
11/2023 - 02/2007
4Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
01/2021 - 06/2015
4Septic Shock (Toxic Shock Syndrome)
03/2010 - 01/2009
3Critical Illness (Critically Ill)
01/2023 - 10/2019
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 12/2020
3Seizures (Absence Seizure)
01/2022 - 05/2018
3Autoimmune Diseases of the Nervous System
01/2022 - 05/2018
3Virus Diseases (Viral Diseases)
08/2021 - 01/2020
3Encephalitis (Encephalitis, Rasmussen)
09/2020 - 05/2018
3Lymphopenia (Lymphocytopenia)
12/2019 - 01/2011
3Infarction (Infarctions)
01/2019 - 01/2011
3Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
02/2016 - 08/2015
3Leukemia
01/2016 - 07/2011
3Bacterial Infections (Bacterial Infection)
01/2012 - 02/2007
2Neuralgia (Stump Neuralgia)
01/2023 - 01/2018
2Spinal Cord Injuries (Spinal Cord Injury)
01/2023 - 11/2013
2Muscle Weakness
02/2022 - 01/2021
2Myositis (Idiopathic Inflammatory Myopathies)
02/2022 - 01/2022
2Myasthenia Gravis
01/2022 - 01/2022
2Systemic Scleroderma (Systemic Sclerosis)
01/2019 - 01/2009
2Wounds and Injuries (Trauma)
10/2018 - 12/2005
2Lubs X-linked mental retardation syndrome
01/2018 - 02/2015
2Neoplasms (Cancer)
11/2016 - 11/2006
2Multiple Sclerosis
01/2016 - 03/2009
2Mannose-Binding Protein Deficiency
10/2015 - 06/2013
2Intellectual Disability (Idiocy)
02/2015 - 10/2010
2Cross Infection (Nosocomial Infection)
10/2013 - 01/2008
2Myocardial Infarction
03/2012 - 01/2004
2Psoriasis (Pustulosis Palmaris et Plantaris)
09/2009 - 08/2007
2Bacteremia
08/2007 - 10/2006
2Body Weight (Weight, Body)
10/2006 - 01/2004
2Heart Failure
10/2004 - 01/2003
1Hypothermia
11/2023
1Superinfection
02/2023

Drug/Important Bio-Agent (IBA)

22Biomarkers (Surrogate Marker)IBA
11/2023 - 10/2009
14HLA-DR Antigens (HLA-DR)IBA
01/2022 - 05/2003
10AntigensIBA
01/2022 - 02/2007
10CytokinesIBA
12/2021 - 09/2003
9AutoantibodiesIBA
01/2023 - 01/2004
9AntibodiesIBA
01/2022 - 01/2009
9Immunoglobulin G (IgG)IBA
01/2022 - 02/2015
7Proteins (Proteins, Gene)FDA Link
02/2023 - 01/2010
7Anti-Bacterial Agents (Antibiotics)IBA
01/2017 - 01/2004
6RNA (Ribonucleic Acid)IBA
02/2023 - 01/2020
6InterferonsIBA
08/2021 - 09/2003
5Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2018 - 10/2009
4Immunoglobulins (Immunoglobulin)IBA
01/2023 - 10/2015
4Monoclonal AntibodiesIBA
01/2022 - 10/2009
4Cholinergic Agents (Cholinergics)IBA
12/2020 - 11/2015
4Interleukin-6 (Interleukin 6)IBA
01/2019 - 07/2008
3ProcalcitoninIBA
02/2023 - 10/2013
3HLA Antigens (Human Leukocyte Antigens)IBA
01/2023 - 03/2010
3Interferon Type IIBA
01/2022 - 08/2021
3salicylhydroxamic acid (SHAM)IBA
01/2016 - 10/2006
3Propranolol (Inderal)FDA LinkGeneric
05/2015 - 09/2003
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2013 - 01/2008
3Moxifloxacin (Avelox)FDA Link
05/2008 - 01/2004
2Interleukin-8 (Interleukin 8)IBA
11/2023 - 01/2009
2Complement System Proteins (Complement)IBA
01/2023 - 01/2022
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2023 - 01/2021
2Creatine Kinase (Creatine Phosphokinase)IBA
02/2022 - 01/2021
2Cholinergic ReceptorsIBA
01/2022 - 02/2016
2daratumumabIBA
01/2022 - 02/2020
2VaccinesIBA
01/2022 - 01/2004
2Oxygen (Dioxygen)IBA
01/2022 - 01/2021
2Myelin-Oligodendrocyte GlycoproteinIBA
01/2021 - 09/2016
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
05/2020 - 11/2015
2Polysaccharides (Glycans)IBA
01/2020 - 01/2018
2Immunoglobulin M (IgM)IBA
01/2018 - 12/2015
2Myelin Basic ProteinIBA
01/2018 - 09/2016
2Interferon-gamma (Interferon, gamma)IBA
01/2018 - 05/2015
2Immunoglobulin A (IgA)IBA
01/2018 - 02/2015
2Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
10/2015 - 06/2013
2Intravenous Immunoglobulins (IVIG)FDA Link
06/2015 - 06/2015
2CatecholaminesIBA
01/2012 - 09/2003
2Interleukin-4 (Interleukin 4)IBA
01/2009 - 04/2008
2Interleukin-10 (Interleukin 10)IBA
04/2008 - 05/2003
1Fatty Acid-Binding ProteinsIBA
11/2023
1Circular RNAIBA
02/2023
1ApolipoproteinsIBA
02/2023

Therapy/Procedure

17Therapeutics
01/2022 - 05/2008
4Immunotherapy
01/2022 - 01/2016
2Wearable Electronic Devices
01/2022 - 01/2020
2Aftercare (After-Treatment)
01/2022 - 01/2022
2Immunomodulation
05/2018 - 02/2007
2Transplantation
02/2014 - 06/2013
1Induced Hypothermia
11/2023